Diagnostyka

Established: 1998

Country: Poland

Investors: MidEuropa

Diagnostyka is the market leader in laboratory diagnostics in Poland, operating a nationwide network of laboratories, blood collection points, and diagnostic imaging facilities. During MidEuropa’s ownership, the company was transformed into a highly scaled and consolidated platform, combining strong organic growth with an active acquisition strategy.

MidEuropa supported the company in building a leading healthcare brand and accelerating its expansion through systematic market consolidation. Over time, Diagnostyka developed a broad network serving both individual patients and a large base of institutional clients.

By 2025, Diagnostyka had become one of the most prominent healthcare platforms in Central and Eastern Europe, culminating in a landmark public listing on the Warsaw Stock Exchange and validating its position as a scalable, market-leading diagnostics business.

Jakub Swadzba

CEO and Founder - Diagnostyka

"We want to thank MidEuropa for their constructive, value-add support during our 14-year partnership. MidEuropa’s investment, which has lasted nearly half of our company’s history, has been transformational. As a management team we have grown and evolved with our business and now feel energised and look forward to the new chapter of working with the public market investors."

>160mn

tests and 25 million patients served

>15x

sales growth

128

add-on acquisitions

Key achievements

Built the market-leading laboratory diagnostics platform in Poland
Developed a nationwide network including over 1,100 blood collection points, 156 laboratories and 19 imaging facilities
Completed 128 M&A transactions, driving rapid market consolidation
Achieved strong long-term growth, with revenues expanding at a 24% CAGR since initial investment
Established one of the most recognisable healthcare brands in Poland

Funding history

Initially acquired by MidEuropa Fund III in 2011 as a platform investment
Further supported through continued investment and acquisition-led expansion
Successfully exited via IPO. At the time of listing, the Diagnostyka IPO was one of the largest IPOs on the Warsaw Stock Exchange in the preceding five years and raised gross proceeds of just over €400 million for MidEuropa’s investors, with the company’s market capitalisation reaching over €1 billion in the first hours of trading

Employment impact